Information Letter on Doribax® 250 mg/500 mg (doripenem): Discontinuation and recall of stock in circulation
2014.03.05
Active substance: doripenem
The company Janssen-Cilag GmbH points out that it will discontinue distribution of the medicinal product Doribax® 250 mg /500 mg (active substance: doripenem). The entire stock still on the market will be recalled on pharmacy level. This recall will begin the end of February 2014 and shall be completed by the end of March 2014.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN